Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 13, 2026

Billionaire Investor Quietly Loads Up On Construction Stocks As One Gets The Axe

View original at finance.yahoo.com
“Also, APi priced a private offering of $500 million in 5.75% senior unsecured notes due 2034.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • APi Group forecasts Q2 2026 revenue of $2.18B–$2.23B, above the consensus estimate of $2.16B

    60% confidence
  • Truist Securities raised its APi Group price forecast from $53 to $55

    60% confidence
  • MasTec anticipates Q2 2026 revenue of approximately $4.3 billion versus the $4.2 billion consensus estimate

    60% confidence
  • MasTec raised its FY26 adjusted EPS guidance from $8.40 to $8.79, above the analyst consensus of $8.51

    60% confidence
  • TD Cowen raised its MasTec estimate from $320 to $445

    60% confidence
  • APi Group priced a private offering of $500M in 5.75% senior unsecured notes due 2034, with proceeds primarily funding acquisitions of Onyx-Fire Protection Services and Wtech Fire Group

    60% confidence
  • MasTec Q1 2026 revenue climbed 34.5% YoY to $3.83 billion, ahead of the $3.49 billion consensus estimate

    60% confidence
  • MasTec Q1 2026 EPS was $1.39, surpassing analyst estimates of $0.99 and rising sharply from $0.51 a year earlier

    60% confidence
  • MasTec expects Q2 2026 adjusted EPS of $2.20, above analyst projections of $2.12

    60% confidence
  • Robert W. Baird raised its MasTec forecast from $348 to $473

    60% confidence
  • UBS raised its APi Group price forecast from $54 to $56

    60% confidence
  • Citigroup raised its MasTec forecast from $440 to $483

    60% confidence
  • Mizuho raised its MasTec price forecast from $428 to $498

    60% confidence
  • Barclays raised its APi Group price forecast from $52 to $54

    60% confidence
  • APi Group raised its FY2026 revenue guidance to $8.48B–$8.68B from the prior range of $8.40B–$8.60B, versus analyst estimates of $8.53B

    60% confidence
  • APi Group Q1 2026 EPS was $0.32, beating analyst estimates of $0.30 and rising 28% year over year

    60% confidence
  • Truist Financial raised its MasTec forecast from $425 to $518

    60% confidence
  • MasTec sees full-year FY26 revenue of about $17.5 billion, above Wall Street expectations of $17.04 billion

    60% confidence
  • Goldman Sachs raised its MasTec forecast from $348 to $487

    60% confidence
  • APi Group Q1 2026 revenue increased 15.3% YoY to $1.98 billion, ahead of the $1.92 billion consensus estimate

    60% confidence

Data points we hold from this source

Barclays · analyst price target54 USD
UBS Group AG · analyst price target56 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Billionaire Investor Quietly Loads Up On Construction Stocks As One Gets The Axe — Source | Via News | Via News